How to appeal a Cigna adult adhd medications denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for adult adhd medications

Cited policy: Express Scripts Coverage Policy — Stimulants and Related Agents (ADHD)

PA required. ESI uses tiered formulary; brands typically Tier 3. Step therapy through preferred generics. DSM-5-TR aligned in 2023+ updates (age 12 onset).

How Cigna denies adult adhd medications — and how to counter it

Where Cigna pushes back: 1) 'Non-formulary' for Qelbree or branded Focalin XR; 2) Quantity limit exceeded (>2 capsules/day Vyvanse); 3) 'Diagnosis not supported — no neuropsychological testing'.

Counter-arguments that hold up: Formulary exception based on documented intolerance/inefficacy of formulary alternatives. Neuropsych testing NOT required by DSM-5-TR; clinical interview using validated instruments (DIVA-5, CAADID, ASRS) is sufficient and is the standard of care per APA. For QL: split-dose pharmacokinetics rationale.

What Cigna typically denies for adult adhd medications

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For adult adhd medications, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the adult adhd medications treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Vyvanse
• Adderall XR
• Concerta
• Focalin XR
• Ritalin LA
• Strattera

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.